# Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector

> **NCT00534378** · PHASE1 · COMPLETED · sponsor: **U.S. Army Office of the Surgeon General** · enrollment: 39 (actual)

## Conditions studied

- Seizures

## Interventions

- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT00534378
- **Lead sponsor:** U.S. Army Office of the Surgeon General
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2007-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00534378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00534378, "Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00534378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*